Better adherence to a transdermal tulobuterol patch than inhaled salmeterol in elderly chronic obstructive pulmonary disease patients

Geriatrics and Gerontology International

Volumn 13, Issue 2, 2013, Pages 398-404

  Mochizuki, Hideaki ^a   Nanjo, Yuta ^a   Takahashi, Hideki ^a  

^a Tokyo Metropolitan Institute of Gerontology   (Japan)

Author keywords

Adherence; Chronic obstructive pulmonary disease; Inhaled salmeterol; Quality of life; Transdermal tulobuterol patch

Indexed keywords

SALMETEROL; TULOBUTEROL;

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CROSSOVER PROCEDURE; DISEASE SEVERITY; FEMALE; HUMAN; JAPANESE; MALE; MEDICATION THERAPY MANAGEMENT; MINI MENTAL STATE EXAMINATION; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITY OF LIFE; SPIROMETRY; ST. GEORGE RESPIRATORY QUESTIONNAIRE; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, INHALATION; ADRENERGIC BETA-2 RECEPTOR AGONISTS; ADRENERGIC BETA-AGONISTS; AGE FACTORS; AGED; AGED, 80 AND OVER; ALBUTEROL; CROSS-OVER STUDIES; EXERCISE TOLERANCE; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; INSPIRATORY CAPACITY; MALE; MAXIMAL MIDEXPIRATORY FLOW RATE; MEDICATION ADHERENCE; MENTAL STATUS SCHEDULE; PULMONARY DIFFUSING CAPACITY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; RESIDUAL VOLUME; SPIROMETRY; TERBUTALINE; TOTAL LUNG CAPACITY; TREATMENT OUTCOME; VITAL CAPACITY; WALKING;

EID: 84875814881     PISSN: 14441586     EISSN: 14470594     Source Type: Journal    
DOI: 10.1111/j.1447-0594.2012.00916.x     Document Type: Article

References (19)

1. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of COPD. 2011 [Cited 9 Jan 2012.] Available from URL: http://www.goldcopd.org/guidelines-global-strategy-for-diagnosis-management.html.
2. The Japan Respiratory Society COPD Guidelines Development Committee. The Guidelines for Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease (COPD) [in Japanese], 3rd edn. Osaka: Medical Review Co., Ltd, 2009.
3. Cochrane MG, Bala MV, Downs KE etal. Inhaled corticosteroids for asthma therapy: patient adherence, devices, and inhalation technique. Chest 2000; 117: 542-550.
4. Sin DD, Tu JV. Underuse of inhaled steroid therapy in elderly patients with asthma. Chest 2001; 119: 720-725.
5. Barr RG, Somers SC, Speizer FE etal. National Asthma Education and Prevention Program (NAEPP). Patient factors and medication guideline adherence among older women with asthma. Arch Intern Med 2002; 162: 1761-1768.
6. Hanania NA, Sharma G, Sharafkhaneh A. COPD in elderly patient. Semin Respir Crit Care Med 2010; 31: 596-606.
7. Charles SM, Blanchette CM, Silver H etal. Adherence to controller therapy for chronic obstructive pulmonary disease: a review. Curr Med Res Opin 2010; 26: 2421-2429.
8. Uematsu T, Nakano M, Kosuge K etal. The pharmacokinetics of the beta 2-adrenoceptor agonist, tulobuterol, given transdermally and by inhalation. Eur J Clin Pharmacol 1993; 44: 361-364.
9. Fukuchi Y, Nagai A, Seyama K etal. Clinical efficacy and safety of transdermal tulobuterol in the treatment of stable COPD: an open-label comparison with inhaled salmeterol. Treat Respir Med 2005; 4: 447-455.
10. Tamura G, Ohta K. Adherence to treatment by patients with asthma or COPD: comparison between inhaled drugs and transdermal patch. Respir Med 2007; 101: 1895-1902.
11. Ichinose M, Seyama K, Nishimura M etal. Additive effects of transdermal tulobuterol to inhaled tiotropium in patients with COPD. Respir Med 2010; 104: 267-274.
12. Abe T, Setoguchi Y, Kono Y etal. Effects of inhaled tiotropium plus transdermal tulobuterol versus tiotropium alone on impulse oscillation system (IOS)-assessed measures of peripheral airway resistance and reactance, lung function and quality of life in patients with COPD: a randomized crossover study. Pulm Pharmacol Ther 2011; 24: 617-624.
13. Sugawara T, Nanjo Y, Yamazaki M etal. Comparison of adherence and efficacy between inhaled salmeterol and transdermal tulobuterol patch in elderly COPD patients. J Am Geriatr Soc 2009; 57: 919-920.
14. Folstein MF, Folstein SE, McHugh PR. "Minimental state"; A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
15. Jones PW, Bosh TK. Quality of life changes in COPD patients treated with salmeterol. Am J Respir Crit Care Med 1997; 155: 1283-1289.
16. Donohue JF, van Noord JA, Bateman ED etal. A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol. Chest 2002; 122: 47-55.
17. Kelloway JS, Wyatt RA, Adlis SA. Comparison of patients' adherence with prescribed oral and inhaled asthma medications. Arch Intern Med 1994; 154: 1349-1352.
18. Jones C, Santanello NC, Boccuzzi SJ etal. Adherence to prescribed treatment for asthma: evidence from pharmacy benefits data. J Asthma 2003; 40: 93-101.
19. Donohue JF, Fogarty C, Lötvall J etal. Once-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropium. Am J Respir Crit Care Med 2010; 182: 155-162.